Ocular Therapeutix partnered with Stark Raving to support the marketing of DEXTENZA, its hands-free ophthalmic steroid treatment, as the company expanded awareness of the product among ophthalmologists and other healthcare professionals. With a differentiated treatment offering in a competitive ophthalmic market, the campaign required messaging and creative that clearly communicated the product’s value while maintaining a consistent brand presence.
The objective was twofold: generate awareness of DEXTENZA’s recent FDA approval of a new indication, allergic conjunctivitis, an approval that offered a significant increase in the addressable patient population and reinforce its expertise as a treatment for ocular pain and inflammation following ophthalmic surgery. This required a cohesive marketing campaign that would engage healthcare providers across multiple channels — each piece reinforcing DEXTENZA’s positioning while supporting sales conversations, conference engagement, and digital outreach.
Working closely with the Ocular Therapeutix team, we created a comprehensive suite of promotional materials tailored to both print and digital environments. Our work included a dedicated landing page, print advertisements, digital banner ads, sales flyers, trade show booth graphics, and conference leave-behinds designed to capture attention and communicate key product benefits.
By maintaining a unified visual identity and consistent messaging throughout the campaign, we helped Ocular Therapeutix deliver a seamless brand experience wherever healthcare professionals encountered DEXTENZA. The result was a versatile collection of marketing assets that supported the product’s visibility across conferences, digital channels, and everyday promotional efforts.
